Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-29 @ 10:37 AM
Study NCT ID:
NCT05024032
Status:
COMPLETED
Last Update Posted:
2024-01-19
First Post:
2021-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-25
First Submit QC Date:
None
Study First Post Date:
2021-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-26
Results First Submit QC Date:
None
Results First Post Date:
2024-01-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-26
Last Update Post Date:
2024-01-19
Last Update Post Date Type:
ACTUAL